Table 2. HMOX1 expression depending on the studied parameters.
| HMOX1MedianN = 82 | P | |
| Women | 53.78 | >0.05 |
| Men | 72.63 | |
| Co-infection | 27.74 | = 0.0204 |
| No co-infection | 78.65 | |
| Age≥40 years | 61.35 | = 0.05 |
| Age<40 years | 102.04 | |
| HCV viremia >600 000 IU/mL | 111.69 | = 0.0006 |
| HCV viremia ≤600 000 IU/mL | 35.80 | |
| IL-28B CC | 81.10 | >0.05 |
| IL-28B not CC | 65.97 | |
| ALT≥50 U/L | 62.16 | >0.05 |
| ALT<50 U/L | 84.66 | |
| G≥2 | 53.78 | = 0.0495 |
| G<2 | 106.98 | |
| S≥2 | 72.55 | >0.05 |
| S<2 | 45.90 | |
| HCV genotype 1 | 91.68 | = 0.0274* |
| HCV genotype 3 | 26.36 | |
| HCV genotype 4 | 17.50 | |
ALT - alanine aminotransferase, genotypes of IL28B: CC and not CC (CT and TT). In liverbiopsy: G- grade of inflammation and necrosis, S-stage of fibrosis.*Genotype 1 versus 3 p = 0.0501, genotype 1 versus 4 p = 0.0344, genotype 3 versus 4 p>0.05.